Recent Updates
Recently added Catalysts
SVA Positive Sentiment

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

Wednesday, July 15, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Sinovac Biotech Ltd. has announced an extension for shareholders to submit payment instructions for its special cash dividend. The dividend, set at $55.00 per common share, is aimed at rewarding valid holders of the company's shares. This extension reflects the company's commitment to its shareholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Extension of deadline provides more time for shareholders.
  • Special cash dividend of $55.00 per share is substantial.
  • Company shows commitment to rewarding shareholders.

Full Press Release Details

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of

Frequently Asked Questions

What is the amount of the special cash dividend?

The special cash dividend is set at $55.00 per common share.

Who is eligible for the special cash dividend?

Valid holders of Sinovac's common shares are eligible for the dividend.

Why was the deadline extended?

The deadline was extended to allow more time for shareholders to submit payment instructions.

What is Sinovac Biotech known for?

Sinovac Biotech is a leading provider of biopharmaceutical products in China.

ShareAdd on Google
Tags: SVA Sinovac cash dividend biopharmaceuticals China
Last updated: Jul 15, 2026

Biotech snapshot

Lead asset
COVID-19 Vaccine, Inactivated, Omicron StrainPhase 3
COVID-19 →